Vaccines Market to Grow at 6.7% CAGR and to Reach US$ 50.42 Billion by 2023, Led by Hepatitis and Influenza

PUNE, India, August 22, 2018 /PRNewswire/ --

ReportsnReports added vaccines market report with major players operating are GlaxoSmithKline, plc (UK), Pfizer, Inc. (US), Merck & Co., Inc. (US), Sanofi Pasteur SA (France), Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (US), Johnson & Johnson (US), MedImmune, LLC (US), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (US), and Panacea Biotec (India).

Browse 93 Market Data Tables and 46 Figures spread through 184 Pages and In-depth TOC on "Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023" at https://www.reportsnreports.com/reports/267258-vaccine-market-by-technology-types-and-by-indications-infectious-diseases-cancer-allergy-diabetes-cardiovascular-disease-with-market-landscape-analysis-global-forecasts-to-2022.html .

The vaccines market is expected to reach USD 50.42 billion by 2023 from USD 36.45 billion in 2018, at a CAGR of 6.7%. Rising prevalence of diseases, increasing government and non-government funding for vaccine development, and increasing company initiatives to enhance R&D are driving the growth of the vaccines market.

Vaccines Market, By Technology 

1 Introduction

2 Conjugate Vaccines

3 Inactivated and Subunit Vaccines

4 Live Attenuated Vaccines

5 Recombinant Vaccines

6 Toxoid Vaccines

Vaccines Market, By Route of Administration 

1 Introduction

2 Intramuscular and Subcutaneous Administrations

3 Oral Administrations

4 Other Routes of Administration

The pneumococcal segment is expected to account for the largest share of the vaccines market in 2018. The large share of this segment can primarily be attributed to increasing government investments in pneumococcal vaccination programs and high incidence of pneumococcal diseases.

Order the "Vaccines Market by Technology (Live, Toxoid, Recombinant), Disease (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR, Varicella, Dengue), Route (IM/SC, Oral), Patient (Pediatric, Adult), Type - Global Forecast to 2023" Report Now at https://www.reportsnreports.com/purchase.aspx?name=267258 .

North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the increasing investments by companies in India and China, rising disposable income, growing number of awareness programs and symposia, and growing venture capital investments.

Target Audience for this Report: 

        
        - Manufacturers and suppliers of vaccines
        - Research and development companies
        - Medical research laboratories
        - Academic medical centers and universities
        - Research and consulting firms
        - Venture capital firms

The study estimates the vaccines market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the vaccines market.

Download the Sample Brochure of Global Vaccines Market Research Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=267258 .

Vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent vaccines segment is projected to register the highest CAGR during the forecast period. Rising prevalence of diseases and increasing government and nongovernment initiatives to promote immunization are the key factors driving the growth of this segment.

The primary interviews conducted for this report can be categorized as follows: 

        
        - By Company Type: Tier 1 - 36%; Tier 2 - 41%; Tier 3 - 23%.
        - By Designation (Supply Side): C-level- 25%; D-level- 29%; others- 46%.
        - By Designation (Demand Side): General Physicians- 38%; Purchase Managers- 29%; Medical
          Researchers- 33%.
        - By Region: North America-40%; Europe-20%; Asia-33%; RoW-7%.

Another research titled report studies veterinary vaccines market is expected to reach USD 8.6 6billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of 5.9% during the forecast period. The key players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France) is available with discount now at https://www.reportsnreports.com/contacts/discount.aspx?name=267954 .

Explore More Reports on Pharmaceuticals at https://www.reportsnreports.com/market-research/pharmaceuticals .

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

        

        Contact: 
        Hrishikesh Patwardhan 
        2nd Floor, Metropole Building, 
        Next to Inox Theatre, 
        Bund Garden Road, Pune - 411001. 
        Maharashtra, India. 
        +1-888-391-5441 
        sales@reportsandreports.com

 

Connect with Us:   LinkedIn: http://www.linkedin.com/company/reportsnreports  RSS/Feeds:  http: //http://www.reportsnreports.com/feed/l-latestreports.xml [http://www.reportsnreports.com/feed/l-latestreports.xml ]

SOURCE ReportsnReports